SCHEMBL4029947

SCHEMBL4029947

Cn1c(-c2sccc2C(=O)NCCc2ccccc2Cl)nc(C(=O)O)c(O)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC1 P07992 1/20 0.47
FEN1 P39748 1/20 0.47
ERCC4 Q92889 1/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
P2RX7 Q99572 7/20 0.41
HIF1A Q16665 2/20 0.41
ABCB11 O95342 1/20 0.40
IL1B P01584 1/20 0.40
RIPK1 Q13546 1/20 0.39
AKT3 Q9Y243 1/20 0.39
TP53 P04637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4027671 0.81 ERCC1 (0.47) ERCC1FEN1ERCC4P2RX7
SCHEMBL4029843 0.80 POLB (0.41) KMT2AKDM4EALDH1A1HPGDMEN1
SCHEMBL4026809 0.79 FEN1 (0.47) ERCC1FEN1ERCC4KMT2AKDM4E
SCHEMBL4029613 0.79 ERCC1 (0.47) ERCC1FEN1ERCC4KMT2AKDM4E
SCHEMBL4027126 0.79 FEN1 (0.47) ERCC1FEN1ERCC4KMT2AKDM4E
SCHEMBL4029253 0.77 FEN1 (0.63) ERCC1FEN1ERCC4KMT2AKDM4E
SCHEMBL4028367 0.77 ERCC1 (0.47) ERCC1FEN1ERCC4KMT2AHPGD
SCHEMBL4026142 0.74 FEN1 (0.57) ERCC1FEN1ERCC4KMT2AALDH1A1
SCHEMBL4028018 0.74 ERCC1 (0.49) ERCC1FEN1ERCC4KMT2AKDM4E
SCHEMBL6621059 0.73 ERCC1 (0.50) ERCC1FEN1ERCC4KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP claimed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US claimed
EP-1470113-B1 PYRIMIDINONE VIRAL POLYMERASE INHIBITORS ANGELETTI P IST RICHERCHE BIO (IT) 2009-01-07 EP disclosed
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2005-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130997-A1 Pyrimidinone viral polymerase inhibitors POLR2A, POLR1E, POLR2E ERCC1 3181/4885FEN1 343/4885ERCC4 1663/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.